Patent · US Active

Compounds for treating beta-amyloidoses

US8613931B2 · kind B2 · utility

5Cited by

0References

15Claims

0Family size

Assignee

AFFIRIS AG · AT

Inventors

Markus Mandler · Wien, AT
Christian Gieffers · Dossenheim, DE
Frank Mattner · Wien, AT
Andrea Dolischka · Wien, AT
Oleksandr Otava · Wien, AT

Key dates

Filing date	Jun 12, 2009
Grant date	Dec 24, 2013
Priority date	—
Expiry date	Aug 4, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of mimotopes in the treatment of diseases associated with β-amyloid formation and/or aggregation (β-Amyloidoses) including Alzheimer's disease, whereby said mimotopes are able to induce the in vivo formation of antibodies directed to Aβ1-40/42, AβpE3-40/42, Aβ3-40/42 and Aβ11-40/42.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.